Because we have previously shown that miR-26a and miR-101 are suppressed in SLE CD4+ T cells compared to normal healthy controls, these data suggest that increased glycolysis might potentially explain EZH2 overexpression in SLE CD4+ T cells. The gene discussed is EZH2; the disease is systemic lupus erythematosus.